271 related articles for article (PubMed ID: 31960208)
21. Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis.
Priori R; Barone F; Alessandri C; Colafrancesco S; McInnes IB; Pitzalis C; Valesini G; Bombardieri M
Rheumatology (Oxford); 2011 Apr; 50(4):776-80. PubMed ID: 21149398
[TBL] [Abstract][Full Text] [Related]
22. Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease.
Chen YM; Hung WT; Chang WC; Hsieh CW; Chung WH; Lan JL; Gung NR; Lee YS; Chen DY; Hung SI
J Immunol Res; 2020; 2020():8640719. PubMed ID: 32149159
[TBL] [Abstract][Full Text] [Related]
23. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
24. Association of the Leukocyte Immunoglobulin-like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult-Onset Still's Disease.
Wang M; Liu M; Jia J; Shi H; Teng J; Liu H; Sun Y; Cheng X; Ye J; Su Y; Chi H; Liu T; Wang Z; Wan L; Meng J; Ma Y; Yang C; Hu Q
Arthritis Rheumatol; 2021 Jun; 73(6):1033-1043. PubMed ID: 33381895
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
27. Serum Interleukin-18 Provides a Clue to the Diagnosis of Adult-Onset Still's Disease: Findings from 6 Japanese Patients with Adult-Onset Still's Disease.
Ogita A; Ansai SI; Saeki H
J Nippon Med Sch; 2022 Mar; 89(1):114-118. PubMed ID: 34526450
[TBL] [Abstract][Full Text] [Related]
28. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
31. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
Liu Y; Xia C; Chen J; Fan C; He J
Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
[TBL] [Abstract][Full Text] [Related]
32. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
33. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
35. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
36. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease.
Park JH; Kim HS; Lee JS; Kim JJ; Jung KH; Park YW; Yoo DH
J Rheumatol; 2012 Oct; 39(10):2000-7. PubMed ID: 22859348
[TBL] [Abstract][Full Text] [Related]
38. The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease.
Jung JY; Suh CH; Kim HA
Expert Rev Mol Diagn; 2019 Jun; 19(6):459-468. PubMed ID: 31055973
[No Abstract] [Full Text] [Related]
39. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
40. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
